The Ministry of Health of the Republic of Kazakhstan has signed a major investment agreement with the Turkish company Nobel to create a new pharmaceutical production facility. According to the press service of the agency, the project is being implemented as part of the instructions of the Head of State and demonstrates the effectiveness of new mechanisms for attracting investment to the industry.
Key Parameters and Timeline
The total investment volume in the project will amount to 40 billion tenge (about $80 million). The construction of the new production complex, complying with international GMP standards, will begin as early as 2026.
The agreement provides for the production of a wide range of medicines, including 17 socially significant drugs and another 40 items of various medicinal products.
Strategic Importance
“We see sustainable dynamics: the pharmaceutical sector demonstrates growth of 10%, and the volume of investments has doubled. This is the result of a systematic state policy for the development of local production”.
— Akmaral Alnazarova, Minister of Health of the Republic of Kazakhstan
According to the head of the Ministry of Health, the implementation of the new project will strengthen the country’s drug security and expand its export potential.
“Our task is to provide the country with high-quality and affordable medicines, as well as to create conditions under which Kazakhstan will become a regional pharmaceutical hub. All necessary legislative conditions for this have already been created”.
— Akmaral Alnazarova, Minister of Health of the Republic of Kazakhstan
Reliable Partner with History
Nobel has been operating in the Kazakhstan market since 2002, establishing JSC “Nobel Almaty Pharmaceutical Factory” (Nobel AFF). The investor possesses years of expertise: in 2011, the factory was the first in the country to receive a GMP certificate and successfully passed a WHO audit.
Today, the enterprise provides jobs for about 500 employees and produces 104 molecules in 228 dosage forms. Products are actively exported to Russia, Kyrgyzstan, Uzbekistan, and Mongolia. The Turkish holding Nobel, founded in 1964, manages plants in Turkey, Kazakhstan, and Uzbekistan, consistently expanding its presence in the region.
